Hypoxia Microenvironment Preconditioning Attenuated Myocardial Ischemia‐Reperfusion Injury via Stc1‐Mediating Cardiomyocyte Self‐Protection and Neutrophil Polarization
Advanced Science · 2025
DOI: 10.1002/advs.202411880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Haoxiang Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue,…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Myocytes, Cardiac, Neutrophils, Hypoxia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, GuangDong Basic and Applied Basic Research Foundation, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Ischemic preconditioning (IPC) therapy application to attenuate myocardial ischemia‐reperfusion (MI/R) injury in clinical practice remains challenging. The secretome, derived from hypoxia‐preconditioned cardiomyocytes (SHPC), potentially mimics the IPC microenvironment and facilitates IPC clinical translation. This study aims to determine whether SHPC can be a feasible alternative to IPC for attenuating MI/R injury, and to identify the functional factor of SHPC. The ultrafiltration technique is applied to generate an SHPC formulation that is intramyocardially injected before reperfusion in a murine MI/R model. The effects of SHPC on cardiomyocyte apoptosis, pyroptosis, and neutrophil polarization are evaluated. Secretomics, neutralizing antibodies, and recombinant proteins are employed to identify the functional factor in SHPC. Co‐immunoprecipitation assays, RNA sequencing, and site‐directed mutagenesis are conducted to investigate the underlying mechanism. Additionally, a recombinant functional factor‐encapsulated hydrogel is developed for intrapericardial injections (iPC). An intramyocardial SHPC injection in MI/R‐injured mice strikingly reduces infarct size and the expression of cardiac injury biomarker while improving cardiac function. SHPC eliminated mitochondrial reactive oxygen species and triggered neutrophil polarization to reduce cardiomyocyte apoptosis/pyroptosis upon hypoxia/reoxygenation injury. Stanniocalcin 1 (Stc1) is identified as the functional factor in SHPC, mediating hypoxic microenvironment. Mechanistically, hypoxia‐preconditioned cardiomyocytes secrete Stc1 into the microenvironment and activate calcium‐sensing receptor (CaSR) that increases Stat3 phosphorylation at Ser727 via nitric oxide synthase 2 (NOS2)‐mediated S‐nitrosylation, thereby decreasing cardiomyocyte apoptosis/pyroptosis in an autocrine mechanism. Simultaneously, Stc1 facilitates cardiomyocyte‐neutrophil crosstalk, thereby triggering neutrophil polarization to reduce inflammatory damage via the CaSR/NOS2/Stat3 axis in a paracrine mechanism. Pericardial delivery of a recombinant rStc1‐encapsulated hydrogel has extended the therapeutic time window of rStc1, improving long‐term cardiac function. The hypoxia microenvironment preconditioning, which mimicked by SHPC, attenuated MI/R injury via Stc1‐mediated cardiomyocyte self‐protection and neutrophil polarization. This study suggests that SHPC, with hypoxia preconditioning factor Stc1, represents a clinically feasible alternative to IPC for attenuating MI/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, China.
- Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangzhou, 510515, China.
- The Tenth Affiliated Hospital of Southern Medical University, Dongguan, Guangdong, 523059, China.
ORCID-Profile: Yanmei Chen
Förderung
- National Natural Science Foundation of China
- GuangDong Basic and Applied Basic Research Foundation
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Huang, H., Ruan, Y., Li, C., Zheng, H., Tang, Y., Chen, Y., He, F., Liu, Y., Wu, G., Li, Z., Wang, Y., Liao, Y., Bin, J., & Chen, Y. (2025). Hypoxia Microenvironment Preconditioning Attenuated Myocardial Ischemia‐Reperfusion Injury via Stc1‐Mediating Cardiomyocyte Self‐Protection and Neutrophil Polarization. Advanced Science. https://doi.org/10.1002/advs.202411880
Vancouver
Huang H, Ruan Y, Li C, Zheng H, Tang Y, Chen Y, et al. Hypoxia Microenvironment Preconditioning Attenuated Myocardial Ischemia‐Reperfusion Injury via Stc1‐Mediating Cardiomyocyte Self‐Protection and Neutrophil Polarization. Advanced Science. 2025. doi:10.1002/advs.202411880
BibTeX
@article{Huang2025,
author = {Huang, Haoxiang and Ruan, Yifei and Li, Chuling and Zheng, Hao and Tang, Yating and Chen, Yijin and He, Fengling and Liu, Yu and Wu, Guangkai and Li, Zhenhua and Wang, Yuegang and Liao, Yulin and Bin, Jianping and Chen, Yanmei},
title = {Hypoxia Microenvironment Preconditioning Attenuated Myocardial Ischemia‐Reperfusion Injury via Stc1‐Mediating Cardiomyocyte Self‐Protection and Neutrophil Polarization},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411880}
}
EUVIMED